Response to "Letter to the Editor Regarding 'Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab vs. Dupilumab in Moderate to Severe Atopic Dermatitis'"

• Hoofdauteurs: Kim Rand (Auteur), Juan Manuel Ramos-Goñi (Auteur), Bülent Akmaz (Auteur), Laia Solé-Feu (Auteur), José-Carlos A (Auteur)
• Formaat: Boek
• Gepubliceerd in: Adis, Springer Healthcare, 2024-03-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.